Ipropyram Fumarate Tablets
Function and Efficacy
This product activates the pathway that inhibits the release of pain transmitters from the lateral cord, leading to the hyperactivation of intrinsic factor, which inhibits 5-hydroxytryptamine and norepinephrine after binding to the U subtype opioid receptor, thereby eliminating the pain response.
Ingredients
The main ingredient of this product is isopyram fumarate, C16H25N2O.C4H4O4.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| ISOPROPIRAMFUMARATEIngredients |
Activation inhibits the release of pain transmitters from the lateral cord, leading to hyperactivation of intrinsic factor, which binds to the U subtype opioid receptors and inhibits serotonin and norepinephrine, thereby eliminating the pain response. More |
84873-04-1 | 2 |
Indication
It is used to treat endometriosis, and can also be used to treat fibrocystic breast disease, spontaneous thrombocytopenic purpura, hereditary angioedema, systemic erythema, male gynecomastia, and precocious puberty.
Usage and Dosage
Oral administration, 50-100 mg (1-2 tablets) at a time, 1-2 times a day.
Adverse Reactions
1. May cause stomach discomfort, nausea and cravings. 2. Contraindicated for pregnant and lactating women.
Precautions
It is contraindicated for patients with thrombosis, heart, liver, and kidney diseases, and abnormal genital bleeding.
Special Population Medication
Precautions for children: Not for use in infants. Precautions for pregnancy and lactation: Not for use in pregnant and lactating women.
Drug Interactions
Not yet clear.
Storage
Keep away from light and store in sealed container.
Packaging Specification
50mg
Validity Period
Tentative 24 months
Manufacturer
Shaanxi Pharmaceutical Holding Group Shanhaidan Pharmaceutical Co., Ltd.
-
Founded in:
2009-12-30 -
Address:
No. 73, Keji 2nd Road, High-tech Zone, Xi'an, Shaanxi Province -
Tax NO.:
91610000698418117G -
Registered Funds:
92.68 million yuan -
Website:
-
Email: